Frequency of PD-L1 positivity and microsatellite instability (MSI) in   the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone   in patients with resectable esophagogastric adenocarcinoma. A   randomized, open-label phase IIb trial of the German gastric group at   the AIO and SAKK

Titel:: Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
Dokumenttyp:: Meeting Abstract
Autor(en):: Kopp, C.; Lorenzen, S.; Gaiser, T.; Thuss-Patience, P. C.; Schenk, M.; Lindig, U.; Kretzschmar, A.; Heuer, V.; Goekkurt, E.; Haag, G. M.; Knorrenschild, J. Riera; Bolling, C.; Hofheinz, R. D.; Siebenhuener, A. R.; Irahara, N.; Waberer, L.; Pauligk, C.; Gotze, T. O.; Homann, N.; Al-Batran, S-E.
Zeitschriftentitel:: Ann Oncol
Jahr:: 2021
Band / Volume:: 32 Suppl 5
Seitenangaben Beitrag:: S1069-S1070
Volltext / DOI:: doi:10.1016/j.annonc.2021.08.1539
Print-ISSN:: 0923-7534
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: